Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Private Companies

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

ProKidney (PROK)

NASDAQ:PROK

US Market

PROK

ProKidney

RESEARCH TOOLSreports

ProKidney (PROK) Stock News & Sentiment

366 Followers

Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability

Company Announcements

Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability

3d ago

ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating

Ratings

ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating

3d ago

Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney

Ratings

Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney

2M ago

ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating

Ratings

ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating

2M ago

ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans

Company Announcements

ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans

2M ago

Advancing Rilparencel in Diabetic CKD: De-Risked PROACT 1 Trial Design and Strong Enrollment Support Buy Rating on ProKidney

Ratings

Advancing Rilparencel in Diabetic CKD: De-Risked PROACT 1 Trial Design and Strong Enrollment Support Buy Rating on ProKidney

2M ago

ProKidney Advances Rilparencel Program and Manufacturing Expansion

Company Announcements

ProKidney Advances Rilparencel Program and Manufacturing Expansion

2M ago

More PROK News >

PROK News on the Web

2026-03-20

Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability

TipRanks News

Bearish

2026-03-19

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)

TipRanks News

Bearish

2026-03-19

Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), HeartFlow, Inc. (HTFL) and Arvinas Holding Company (ARVN)

TipRanks News

Neutral

2026-03-19

ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating

TipRanks News

Neutral

2026-03-19

Guggenheim Sticks to Its Buy Rating for ProKidney (PROK)

TipRanks News

Bullish

2026-03-19

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Dogwood Therapeutics (DWTX) and Precision BioSciences (DTIL)

TipRanks News

Bullish

2026-03-19

ProKidney Expects Phase 3 PROACT 1 Pivotal Trial Results For Rilparencel In Q2 2027

rttnews

Bullish

2026-03-18

ProKidney reports Q4 EPS (52c), consensus (15c)

TipRanks News

Bullish

News Score - Last 7 Days

Neutral

PROK

Sector Average

Media Buzz

This Week8 articles

Weekly Average2.5 articles

News Sentiment

This Week67%

Sector Average67%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PROK’s Media Buzz Sentiment?

8 articles about PROK were published this week. In an average week, 2.5 articles are published.

What is PROK’s weekly average amount of articles?

In an average week, 2.5 articles about PROK are published.

What is PROK’s News Sentiment?

67% of articles about PROK were positive this week, compared to its sector average of 67%.

Healthcare Stocks that are Trending in the News

KHTRFKnight Therapeutics

ABOSAcumen Pharmaceuticals

KMTSKestra Medical Technologies Ltd.

MISTMilestone Pharmaceuticals

OVIDOvid Therapeutics

Showing the stocks with the most bullish news sentiment over the past week